Lesser eGFR Decline with Dulaglutide Regardless of Weight Changes in People with Type 2 Diabetes and Moderate to Severe Chronic Kidney Disease (AWARD-7)

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1066-P ◽  
Author(s):  
KATHERINE R. TUTTLE ◽  
MARK LAKSHMANAN ◽  
BRIAN L. RAYNER ◽  
ROBERT S. BUSCH ◽  
ALAN G. ZIMMERMANN ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Weight Changes ◽  
Severe Chronic Kidney Disease ◽  
Egfr Decline

scholarly journals FO022BARDOXOLONE METHYL PREVENTS EGFR DECLINE IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 4 AND TYPE 2 DIABETES - POST-HOC ANALYSES FROM BEACON

2018 ◽  
Vol 33 (suppl_1) ◽  
pp. i10-i10
Author(s):  
Christoph Wanner ◽  
George Bakris ◽  
Geoffrey Block ◽  
Melanie Chin ◽  
Angie Goldsberry ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Chronic Kidney Disease Stage ◽  
Disease Stage ◽  
Stage 4 ◽  
Post Hoc ◽  
Egfr Decline

Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate‐to‐severe chronic kidney disease (AWARD‐7)

2019 ◽  
Vol 21 (6) ◽  
pp. 1493-1497 ◽  
Author(s):  
Katherine R. Tuttle ◽  
Mark C. Lakshmanan ◽  
Brian Rayner ◽  
Alan G. Zimmermann ◽  
Brad Woodward ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Body Weight ◽  
Kidney Disease ◽  
Severe Chronic Kidney Disease

949-P: Dulaglutide Improves Kidney Fibrosis Biomarker Levels in Patients with Type 2 Diabetes and Moderate-to-Severe Chronic Kidney Disease

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 949-P
Author(s):  
KATHERINE R. TUTTLE ◽  
JONATHAN M. WILSON ◽  
YANZHU LIN ◽  
HUI-RONG QIAN ◽  
KATHLEEN KELLY-BORUFF ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Kidney Fibrosis ◽  
Severe Chronic Kidney Disease
Sign in / Sign up

Export Citation Format

Share Document